<DOC>
	<DOCNO>NCT00939276</DOCNO>
	<brief_summary>The purpose study evaluate NEVANAC patient diabetic retinopathy develop macular edema ( ME ) within 90 day follow cataract surgery .</brief_summary>
	<brief_title>Macular Edema Incidence/Severity Reduction With Nevanac</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<criteria>Planned cataract extraction phacoemulsification implantation posterior chamber intraocular lens ( IOL ) lens capsule . History Type 1 Type 2 diabetes . History nonproliferative diabetic retinopathy ( NPDR ) , mild , moderate , severe , study eye define International Clinical Diabetic Retinopathy Disease Severity Scale . Able understand sign inform consent approve IRB/IEC . Central subfield macular thickness le equal 320 Î¼m study eye prior cataract surgery . Absence clinically significant macular edema study eye detect clinical exam . Other protocoldefined inclusion criterion may apply . Signs vitreomacular traction epiretinal membrane study eye detect read center Investigator . Current previous ocular disease diabetic retinopathy study eye , opinion Investigator , would confound assessment macula , retina , central vision . Planned multiple procedure study eye cataract/IOL implantation surgery ( eg , trabeculoplasty , corneal transplant ) . Corneal transplant study eye . Baseline cumulative corneal fluorescein stain score ( ie , sum score 5 corneal region ) study eye great equal 5 , baseline corneal fluorescein stain score single region study eye great equal 3 . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>cataract surgery</keyword>
	<keyword>macular edema</keyword>
	<keyword>prevention</keyword>
</DOC>